Impact of the withdrawal of macrotextured implant on reconstruction practices.
Fiche publication
Date publication
décembre 2023
Journal
Bulletin du cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles
Tous les auteurs :
Martinez M, Jankowski C, Vincent L, Burnier P, Coutant C
Lien Pubmed
Résumé
On 22 November 2018, the French Society for Plastic, Reconstructive and Aesthetic Surgery recommended that Allergan® macrotextured breast implants be recalled, a decision endorsed by the French national health products safety agency (ANSM) on 2nd April 2019. At the Georges-François Leclerc Cancer Center (CGFL) in Dijon, we decided to stop using macrotextured implants as of November 2018 in favor of smooth implants. The purpose of this study is to evaluate the impact of the recall of macrotextured implants on breast reconstruction surgical practices and their complications.
Mots clés
BIA-LCL, Breast cancer, Breast implant, Breast reconstruction, DIEP, MSLD
Référence
Bull Cancer. 2023 12 8;: